The global serum-free media (SFM) market reached a value of US$ 1.3 billion in 2023. Looking ahead, the IMARC Group projects the market will grow to US$ 2.7 billion by 2032, with a compound annual growth rate (CAGR) of 8.19% from 2024 to 2032. Key factors driving this growth include the increasing prevalence of infectious and chronic diseases, the rising adoption of SFM in biotechnology and pharmaceutical sectors, and growing awareness of its various advantages.
SFM is a specialized cell culture media that excludes animal-derived serum, instead utilizing defined components such as amino acids, vitamins, hormones, and growth factors to support cell growth and proliferation. This serum-free approach allows for more precise control in cell culture environments, as components can be tailored to meet specific requirements. SFM offers several benefits, including improved performance consistency, enhanced cell growth and productivity, better control over physiological responses, and reduced risk of contamination from adventitious agents found in serum. These attributes make SFM a preferred choice in biopharmaceutical production, helping minimize the introduction of unknown variables into the manufacturing process. For more details, visit us: https://www.imarcgroup.com/serum-free-media-market
SFM is a specialized cell culture media that excludes animal-derived serum, instead utilizing defined components such as amino acids, vitamins, hormones, and growth factors to support cell growth and proliferation. This serum-free approach allows for more precise control in cell culture environments, as components can be tailored to meet specific requirements. SFM offers several benefits, including improved performance consistency, enhanced cell growth and productivity, better control over physiological responses, and reduced risk of contamination from adventitious agents found in serum. These attributes make SFM a preferred choice in biopharmaceutical production, helping minimize the introduction of unknown variables into the manufacturing process. For more details, visit us: https://www.imarcgroup.com/serum-free-media-market
The global serum-free media (SFM) market reached a value of US$ 1.3 billion in 2023. Looking ahead, the IMARC Group projects the market will grow to US$ 2.7 billion by 2032, with a compound annual growth rate (CAGR) of 8.19% from 2024 to 2032. Key factors driving this growth include the increasing prevalence of infectious and chronic diseases, the rising adoption of SFM in biotechnology and pharmaceutical sectors, and growing awareness of its various advantages.
SFM is a specialized cell culture media that excludes animal-derived serum, instead utilizing defined components such as amino acids, vitamins, hormones, and growth factors to support cell growth and proliferation. This serum-free approach allows for more precise control in cell culture environments, as components can be tailored to meet specific requirements. SFM offers several benefits, including improved performance consistency, enhanced cell growth and productivity, better control over physiological responses, and reduced risk of contamination from adventitious agents found in serum. These attributes make SFM a preferred choice in biopharmaceutical production, helping minimize the introduction of unknown variables into the manufacturing process. For more details, visit us: https://www.imarcgroup.com/serum-free-media-market
0 Comments
0 Shares